Volume | 115,821 |
|
|||||
News | - | ||||||
Day High | 0.013 | Low High |
|||||
Day Low | 0.0002 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Sorrento Therapeutics Inc (CE) | SRNE | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0002 | 0.0002 | 0.013 | 0.0002 | 0.012 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
40 | 115,821 | US$ 0.0002 | US$ 23 | - | 0.0001 - 0.08475 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:57:39 | 5 | US$ 0.015 | USD |
Sorrento Therapeutics Inc (CE) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 110.26k | 551.28M | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Sorrento Therapeutics (CE) News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRNE Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0135 | 0.016 | 0.0002 | 0.013027 | 71,610 | -0.0133 | -98.52% |
1 Month | 0.0006 | 0.05 | 0.0001 | 0.0157112 | 121,722 | -0.0004 | -66.67% |
3 Months | 0.016 | 0.08475 | 0.0001 | 0.0235649 | 190,357 | -0.0158 | -98.75% |
6 Months | 0.016 | 0.08475 | 0.0001 | 0.0235649 | 190,357 | -0.0158 | -98.75% |
1 Year | 0.016 | 0.08475 | 0.0001 | 0.0235649 | 190,357 | -0.0158 | -98.75% |
3 Years | 0.016 | 0.08475 | 0.0001 | 0.0235649 | 190,357 | -0.0158 | -98.75% |
5 Years | 0.016 | 0.08475 | 0.0001 | 0.0235649 | 190,357 | -0.0158 | -98.75% |
Sorrento Therapeutics (CE) Description
Sorrento Therapeutics, Inc. (STI) provides access to its novel and proprietary technology platform for the construction of fully human antibody libraries, the STI Technology. The STI Technology applies RNA transcription for the amplification of human immunoglobin variable domain sequences. |